Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

London midday: Resource stocks lift Footsie, Gulf Keystone jumps

Tue, 10th Jan 2012 12:00

Resource stocks performed well in morning trade, lifting the FTSE 100 over 1.1% higher. Miners were gaining ground after some positive economic data from China boosted sentiment, while Cairn Energy was on the up after detailing its $3.5bn cash return to shareholders.A big mover was Gulf Keystone, the AIM-listed oil and gas firm, which shot up over 16% on unconfirmed speculation that it could be sold, according to Bloomberg. Gulf Keystone reported this morning an agreement over options at two of its sites with the Kurdistan Regional Government (KRG). The firm has agreed that the KRG may assign an interest to a third party in both the Shaikan and Akri-Bijeel blocks.RESOURCES STOCKS PROVIDE A BOOSTWith Chinese foreign trade data beating expectations, the miners were on the rise in the opening minutes. Vedanta Resources, Antofagasta and Kazakhmys were providing a lift, while Burberry - the luxury firm sensitive to developments in the Chinese economy - was also in demand. China's trade balance widened from $145.3bn to $165.2bn in December and while import growth had slowed, imports for copper and aluminium accelerated.Oil and gas firm Cairn Energy was a high riser after giving details of the long-awaited $3.5bn it intends to return to its lucky shareholders following the $5.5bn sale of a large stake in its Indian business to Vedanta. The return of cash will take place as a 'B' sharescheme which will give UK tax-payers the chance to receive cash in the form of income or capital, or a blend of both. Oriel Securities upgraded the stock from hold to add this morning.RETAILERS IN FASHIONHigh street giant Marks & Spencer rose after seeing sales (excluding VAT) rise 2.4% in the final 13 weeks of 2011. As for the all-important like-for-like sales comparisons, overall, the UK stores were up 0.5%, with General Merchandise down 1.8% but Food up 3.0%.Another retailer, FTSE 250 department store chain Debenhams, also issued a trading statement today and saw its share price jump 10%. The firm reported 6.5% improvement in like-for-like (LFL) sales including VAT in December."All in all, we've seen some cracking results this morning from two of Britain's leading high street retailers," said Cavendish Asset Management's Senior Fund Manager Paul Mumford. "The gloom and doom factor regarding Marks & Spencer and Debenhams was palpable last week; commentators and analysts have were in the main deeply pessimistic ahead of today's results. Yet in both cases results have exceeded expectations, and we are seeing relief rallies as a result," he said.Helping the rally in the retail sector, which was gaining an average 1.9%, was the news that retail LFL sales rose 2.2% in December. In other company movements, banks were putting in a good performance with Barclays leading the way gaining nearly 5%, despite having its target price cut by UBS. The Swiss broker has reduced its earnings forecasts by 1% and 6% for 2011 and 2012, respectively, on the back of a "uncertain outlook". Sector peers Lloyds and RBS were also registering decent gains despite the latter being on the verge of shedding between 3,000 and 4,000 jobs, according to Reuters.Just nine stocks were in the red on the FTSE 100 by midday, with defensive pharma peers GlaxoSmithKline and AstraZeneca among them. Tesco edged lower after Bank of America Merrill Lynch downgraded its rating to neutral from buy.BCFTSE 100 - RisersVedanta Resources (VED) 1,035.00p +5.83%Barclays (BARC) 187.00p +5.00%Antofagasta (ANTO) 1,293.00p +4.78%Kazakhmys (KAZ) 1,021.00p +4.29%Johnson Matthey (JMAT) 2,002.00p +4.16%Fresnillo (FRES) 1,700.00p +3.79%BAE Systems (BA.) 300.10p +3.77%Burberry Group (BRBY) 1,322.00p +3.44%Royal Bank of Scotland Group (RBS) 20.74p +3.34%CRH (CRH) 1,246.00p +3.32%FTSE 100 - FallersGlaxoSmithKline (GSK) 1,412.50p -1.57%Sage Group (SGE) 297.60p -0.70%Aggreko (AGK) 2,118.00p -0.61%AstraZeneca (AZN) 2,991.50p -0.58%Smith & Nephew (SN.) 597.50p -0.50%ARM Holdings (ARM) 610.00p -0.49%Shire Plc (SHP) 2,166.00p -0.18%SABMiller (SAB) 2,337.50p -0.17%Tesco (TSCO) 390.15p -0.08%FTSE 250 - RisersDebenhams (DEB) 62.55p +9.93%Talvivaara Mining Company (TALV) 279.60p +5.95%Centamin (DI) (CEY) 85.55p +5.81%Afren (AFR) 109.50p +4.58%Victrex (VCT) 1,170.00p +4.46%Yule Catto & Co (YULC) 178.60p +4.02%JPMorgan Indian Inv Trust (JII) 340.00p +3.91%Henderson Group (HGG) 101.40p +3.68%Aquarius Platinum Ltd. (AQP) 169.30p +3.67%Exillon Energy (EXI) 287.90p +3.60%FTSE 250 - FallersParagon Group Of Companies (PAG) 170.60p -4.21%Redrow (RDW) 119.20p -2.53%Hays (HAS) 63.70p -2.52%Rathbone Brothers (RAT) 1,012.00p -2.50%Ocado Group (OCDO) 54.90p -1.96%Ophir Energy (OPHR) 307.20p -1.85%Kier Group (KIE) 1,394.00p -1.83%Grainger (GRI) 103.10p -1.81%Galliford Try (GFRD) 469.90p -1.69%Synergy Health (SYR) 859.50p -1.66%

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.